References
- Alberti, K. G., Zimmet, P., & Shaw, J. (2005). The metabolic syndrome–a new worldwide definition. Lancet (London, England), 366(9491), 1059–1062. doi:https://doi.org/10.1016/S0140-6736(05)67402-8
- Andersson, T., Alfredsson, L., Källberg, H., Zdravkovic, S., & Ahlbom, A. (2005). Calculating Measures of Biological Interaction. European Journal of Epidemiology, 20(7), 575–579. doi:https://doi.org/10.1007/s10654-005-7835-x
- Arve, S., Tilvis, R. S., Lehtonen, A., Valvanne, J., & Sairanen, S. (1999). Coexistence of lowered mood and cognitive impairment of elderly people in five birth cohorts. Aging Clinical and Experimental Research, 11(2), 90–95. doi:https://doi.org/10.1007/BF03399646
- Awadalla, P., Boileau, C., Payette, Y., Idaghdour, Y., Goulet, J.-P., Knoppers, B., … Laberge, C. (2013). Cohort profile of the CARTaGENE study: Quebec's population-based biobank for public health and personalized genomics . International Journal of Epidemiology, 42(5), 1285–1299. doi:https://doi.org/10.1093/ije/dys160
- Batty, G. D., Deary, I. J., & Gottfredson, L. S. (2007). Premorbid (early life) IQ and later mortality risk: Systematic review. Annals of Epidemiology, 17(4), 278–288. doi:https://doi.org/10.1016/j.annepidem.2006.07.010
- Cannon, D. S., Tiffany, S. T., Coon, H., Scholand, M. B., McMahon, W. M., & Leppert, M. F. (2007). The PHQ-9 as a brief assessment of lifetime major depression. Psychological Assessment, 19(2), 247–251. doi:https://doi.org/10.1037/1040-3590.19.2.247
- Chang, T.-T., Lung, F.-W., & Yen, Y.-C. (2015). Depressive symptoms, cognitive impairment, and metabolic syndrome in community-dwelling elderly in Southern Taiwan Depressive, cognitive, metabolic. Psychogeriatrics : The Official Journal of the Japanese Psychogeriatric Society, 15(2), 109–115. doi:https://doi.org/10.1111/psyg.12080
- Chibnik, L. B., Wolters, F. J., Bäckman, K., Beiser, A., Berr, C., Bis, J. C., … Hofman, A. (2017). Trends in the incidence of dementia: Design and methods in the Alzheimer Cohorts Consortium. European Journal of Epidemiology, 32(10), 931–938. doi:https://doi.org/10.1007/s10654-017-0320-5
- Craig, C. L., Marshall, A. L., Sjöström, M., Bauman, A. E., Booth, M. L., Ainsworth, B. E., … Oja, P. (2003). International physical activity questionnaire: 12-country reliability and validity. Medicine and Science in Sports and Exercise, 35(8), 1381–1395. doi:https://doi.org/10.1249/01.MSS.0000078924.61453.FB
- Cullen, B., Nicholl, B. I., Mackay, D. F., Martin, D., Ul-Haq, Z., McIntosh, A., … Smith, D. J. (2015). Cognitive function and lifetime features of depression and bipolar disorder in a large population sample: Cross-sectional study of 143,828 UK Biobank participants. European Psychiatry : The Journal of the Association of European Psychiatrists, 30(8), 950–958. doi:https://doi.org/10.1016/j.eurpsy.2015.08.006
- Danna, S. M., Graham, E., Burns, R. J., Deschênes, S. S., & Schmitz, N. (2016). Association between depressive symptoms and cognitive function in persons with diabetes mellitus: A systematic review. PLoS One, 11(8), e0160809. doi:https://doi.org/10.1371/journal.pone.0160809
- Delisle, H., Désilets, M.-C., Vargas, E. R., & Garrel, D. (2008). Metabolic syndrome in three ethnic groups using current definitions. Applied Physiology, Nutrition, and Metabolism, 33(2), 356–360. doi:https://doi.org/10.1139/H08-003
- Dik, M. G., Jonker, C., Comijs, H. C., Deeg, D. J. H., Kok, A., Yaffe, K., & Penninx, B. W. (2007). Contribution of metabolic syndrome components to cognition in older individuals. Diabetes Care, 30(10), 2655–2660. doi:https://doi.org/10.2337/dc06-1190
- Gao, S., Burney, H. N., Callahan, C. M., Purnell, C. E., & Hendrie, H. C. (2019). Incidence of dementia and Alzheimer disease over time: A meta‐analysis. Journal of the American Geriatrics Society, 67(7), 1361–1369. doi:https://doi.org/10.1111/jgs.16027
- Gauthier, S., Reisberg, B., Zaudig, M., Petersen, R., Ritchie, K., Broich, K., … … Winblad, B. (2006). Mild cognitive impairment. The Lancet), 367(9518), 1262–1270. doi:https://doi.org/10.1016/S0140-6736(06)68542-5
- Hagenaars, S. P., Harris, S. E., Davies, G., Hill, W. D., Liewald, D. C. M., Ritchie, S. J., … Deary, I. J. (2016). Shared genetic aetiology between cognitive functions and physical and mental health in UK Biobank (N = 112 151) and 24 GWAS consortia. Molecular Psychiatry, 21(11), 1624–1632. doi:https://doi.org/10.1038/mp.2015.225
- Hasselbalch, B. J., Knorr, U., Hasselbalch, S. G., Gade, A., & Kessing, L. V. (2013). The cumulative load of depressive illness is associated with cognitive function in the remitted state of unipolar depressive disorder. Eur. Psychiatry, 28(6), 349–355. doi:https://doi.org/10.1016/j.eurpsy.2012.03.004
- Hassenstab, J. J., Sweat, V., Bruehl, H., & Convit, A. (2010). Metabolic syndrome is associated with learning and recall impairment in middle age. Dementia and Geriatric Cognitive Disorders, 29(4), 356–362. doi:https://doi.org/10.1159/000296071
- Huang, P. L. (2009). A comprehensive definition for metabolic syndrome. Disease Models & Mechanisms, 2(5–6), 231–237. doi:https://doi.org/10.1242/dmm.001180
- Hurd, M. D., Martorell, P., Delavande, A., Mullen, K. J., & Langa, K. M. (2013). Monetary costs of dementia in the United States. The New England Journal of Medicine, 368(14), 1326–1334. doi:https://doi.org/10.1056/NEJMsa1204629
- Hystad, P., Payette, Y., Noisel, N., & Boileau, C. (2019). Green space associations with mental health and cognitive function: Results from the Quebec CARTaGENE cohort. Environmental Epidemiology, 3(1), e040. p doi:https://doi.org/10.1097/EE9.0000000000000040
- Jaeger, J., Berns, S., Uzelac, S., & Davis-Conway, S. (2006). Neurocognitive deficits and disability in major depressive disorder. Psychiatry Research, 145(1), 39–48. doi:https://doi.org/10.1016/j.psychres.2005.11.011
- Juster, R.-P., McEwen, B. S., & Lupien, S. J. (2010). Allostatic load biomarkers of chronic stress and impact on health and cognition. Neuroscience and Biobehavioral Reviews, 35(1), 2–16. doi:https://doi.org/10.1016/j.neubiorev.2009.10.002
- Kalilani, L., & Atashili, J. (2006). Measuring additive interaction using odds ratios. Epidemiologic Perspectives & Innovations : Ep + I, 3(1), 5pdoi:https://doi.org/10.1186/1742-5573-3-5 Retrieved from
- Kroenke, K., Spitzer, R. L., & Williams, J. B. (2001). The PHQ‐9: Validity of a brief depression severity measure. Journal of General Internal Medicine, 16(9), 606–613. doi:https://doi.org/10.1046/j.1525-1497.2001.016009606.x
- Lamers, F., Jonkers, C. C. M., Bosma, H., Penninx, B. W. J. H., Knottnerus, J. A., & van Eijk, J. T. M. (2008). Summed score of the Patient Health Questionnaire-9 was a reliable and valid method for depression screening in chronically ill elderly patients. Journal of Clinical Epidemiology, 61(7), 679–687. doi:https://doi.org/10.1016/j.jclinepi.2007.07.018
- Livingston, G., Sommerlad, A., Orgeta, V., Costafreda, S. G., Huntley, J., Ames, D., … Mukadam, N. (2017). Dementia prevention, intervention, and care. Lancet (London, England), 390(10113), 2673–2734. doi:https://doi.org/10.1016/S0140-6736(17)31363-6
- Lyall, D. M., Celis-Morales, C. A., Anderson, J., Gill, J. M., Mackay, D. F., McIntosh, A. M., … Pell, J. P. (2017). Associations between single and multiple cardiometabolic diseases and cognitive abilities in 474 129 UK Biobank participants. Eur Heart J, 38(8), 577–583. doi:https://doi.org/10.1093/eurheartj/ehw528Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/28363219
- Malhotra, C., Chan, A., Matchar, D., Seow, D., Chuo, A., & Do, Y. K. (2013). Diagnostic performance of short portable mental status questionnaire for screening dementia among patients attending cognitive assessment clinics in Singapore. Annals of the Academy of Medicine Singapore, 42(7), 315–319.
- Mirza, S. S., Wolters, F. J., Swanson, S. A., Koudstaal, P. J., Hofman, A., Tiemeier, H., & Ikram, M. A. (2016). 10-year trajectories of depressive symptoms and risk of dementia: A population-based study. The Lancet Psychiatry, 3(7), 628–635. doi:https://doi.org/10.1016/S2215-0366(16)00097-3
- Mourao, R. J., Mansur, G., Malloy-Diniz, L. F., Castro Costa, E., & Diniz, B. S. (2016). Depressive symptoms increase the risk of progression to dementia in subjects with mild cognitive impairment: Systematic review and meta-analysis. International Journal of Geriatric Psychiatry, 31(8), 905–911. doi:https://doi.org/10.1002/gps.4406
- Naismith, S. L., Longley, W. A., Scott, E. M., & Hickie, I. B. (2007). Disability in major depression related to self-rated and objectively-measured cognitive deficits: A preliminary study. BMC Psychiatry, 7(1), 32. doi:https://doi.org/10.1186/1471-244X-7-32
- Pal, K., Mukadam, N., Petersen, I., & Cooper, C. (2018). Mild cognitive impairment and progression to dementia in people with diabetes, prediabetes and metabolic syndrome: A systematic review and meta-analysis. Social Psychiatry and Psychiatric Epidemiology, 53(11), 1149–1160. doi:https://doi.org/10.1007/s00127-018-1581-3
- Pan, A., Keum, N., Okereke, O. I., Sun, Q., Kivimaki, M., Rubin, R. R., & Hu, F. B. (2012). Bidirectional association between depression and metabolic syndrome: A systematic review and meta-analysis of epidemiological studies. Diabetes Care, 35(5), 1171–1180. doi:https://doi.org/10.2337/dc11-2055
- Philippou, E., Michaelides, M. P., & Constantinidou, F. (2018). The role of metabolic syndrome factors on cognition using latent variable modeling: The neurocognitive study on aging. Journal of Clinical and Experimental Neuropsychology, 40(10), 1030–1043. doi:https://doi.org/10.1080/13803395.2018.1483487
- Prince, M., Bryce, R., Albanese, E., Wimo, A., Ribeiro, W., & Ferri, C. P. (2013). The global prevalence of dementia: A systematic review and metaanalysis. Alzheimer's & Dementia, 9(1), 63–75. e62. doi:https://doi.org/10.1016/j.jalz.2012.11.007
- Qiu, C., & Fratiglioni, L. (2015). A major role for cardiovascular burden in age-related cognitive decline. Nature Reviews Cardiology, 12(5), 267–277. p doi:https://doi.org/10.1038/nrcardio.2014.223
- Razzouk, L., & Muntner, P. (2009). Ethnic, gender, and age-related differences in patients with the metabolic syndrome. Current Hypertension Reports, 11(2), 127–132. doi:https://doi.org/10.1007/s11906-009-0023-8
- Reppermund, S., Brodaty, H., Crawford, J. D., Kochan, N. A., Draper, B., Slavin, M. J., … Sachdev, P. S. (2013). Impairment in instrumental activities of daily living with high cognitive demand is an early marker of mild cognitive impairment: The Sydney Memory and Ageing Study. Psychological Medicine, 43(11), 2437–2445. doi:https://doi.org/10.1017/S003329171200308X
- Ritchie, K. (2004). Mild cognitive impairment: An epidemiological perspective. Dialogues in Clinical Neuroscience, 6(4), 401–408.
- Rock, P., Roiser, J., Riedel, W., & Blackwell, A. (2014). Cognitive impairment in depression: A systematic review and meta-analysis. Psychological Medicine, 44(10), 2029–2040. doi:https://doi.org/10.1017/S0033291713002535
- Roehr, S., Pabst, A., Luck, T., & Riedel-Heller, S. G. (2018). Is dementia incidence declining in high-income countries? A systematic review and meta-analysis. Clinical Epidemiology, Volume 10p, 1233–1247. doi:https://doi.org/10.2147/CLEP.S163649
- Rossor, M. N., Fox, N. C., Mummery, C. J., Schott, J. M., & Warren, J. D. (2010). The diagnosis of young-onset dementia. The Lancet Neurology, 9(8), 793–806. doi:https://doi.org/10.1016/S1474-4422(10)70159-9
- S Liu, C., F Carvalho, A., & S McIntyre, R. (2014). Towards a “metabolic” subtype of major depressive disorder: Shared pathophysiological mechanisms may contribute to cognitive dysfunction. CNS & Neurological Disorders Drug Targets, 13(10), 1693–1707. doi:https://doi.org/10.2174/1871527313666141130204031
- Schmitz, N., Deschênes, S. S., Burns, R. J., Danna, S. M., Franco, O. H., Ikram, M. A., … Tiemeier, H. (2018). Cardiometabolic dysregulation and cognitive decline: Potential role of depressive symptoms. The British Journal of Psychiatry : The Journal of Mental Science, 212(2), 96–102. doi:https://doi.org/10.1192/bjp.2017.26 Retrieved from < Go to ISI>://WOS:000424024500007
- Schmitz, N., Deschênes, S. S., Burns, R. J., Smith, K. J., Lesage, A., Strychar, I., … Wang, J. L. (2016). Depression and risk of type 2 diabetes: The potential role of metabolic factors. Molecular Psychiatry, 21(12), 1726–1732. doi:https://doi.org/10.1038/mp.2016.7
- Sperling, R., Mormino, E., & Johnson, K. (2014). The evolution of preclinical Alzheimer’s disease: Implications for prevention trials. NEURON - Neuron, 84(3), 608–622. doi:https://doi.org/10.1016/j.neuron.2014.10.038
- Tan, A. K., Dunn, R. A., & Yen, S. T. (2011). Ethnic disparities in metabolic syndrome in Malaysia: An analysis by risk factors. Metabolic Syndrome and Related Disorders, 9(6), 441–451. doi:https://doi.org/10.1089/met.2011.0031
- Teixeira, P. J., & Rocha, F. L. (2007). The prevalence of metabolic syndrome among psychiatric inpatients in Brazil. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil : 1999), 29(4), 330–336. doi:https://doi.org/10.1590/S1516-44462007000400007
- Toups, M. S., & Trivedi, M. H. (2011). Role of metabolic dysfunction in treatment resistance of major depressive disorder. Neuropsychiatry, 1(5), 441–455. doi:https://doi.org/10.2217/npy.11.49
- Vogelzangs, N., Beekman, A. T., Boelhouwer, I. G., Bandinelli, S., Milaneschi, Y., Ferrucci, L., & Penninx, B. W. (2011). Metabolic depression: A chronic depressive subtype? Findings from the InCHIANTI study of older persons. The Journal of Clinical Psychiatry, 72(5), 598–604. doi:https://doi.org/10.4088/JCP.10m06559
- Vogelzangs, N., Beekman, A. T., van Reedt Dortland, A. K., Schoevers, R. A., Giltay, E. J., de Jonge, P., & Penninx, B. W. (2014). Inflammatory and metabolic dysregulation and the 2-year course of depressive disorders in antidepressant users. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology, 39(7), 1624–1634. doi:https://doi.org/10.1038/npp.2014.9
- Watari, K., Letamendi, A., Elderkin-Thompson, V., Haroon, E., Miller, J., Darwin, C., & Kumar, A. (2006). Cognitive function in adults with type 2 diabetes and major depression. Archives of Clinical Neuropsychology : The Official Journal of the National Academy of Neuropsychologists, 21(8), 787–796. doi:https://doi.org/10.1016/j.acn.2006.06.014
- World Health Organization. (2019). Risk reduction of cognitive decline and dementia: WHO guidelines. https://www.who.int/mental_health/neurology/dementia/guidelines_risk_reduction/en/.
- Xue, M., Xu, W., Ou, Y.-N., Cao, X.-P., Tan, M.-S., Tan, L., & Yu, J.-T. (2019). Diabetes mellitus and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 144 prospective studies. Ageing Research Reviews, 55, 100944. doi:https://doi.org/10.1016/j.arr.2019.100944
- Yaffe, K., Kanaya, A., Lindquist, K., Simonsick, E. M., Harris, T., Shorr, R. I., … Newman, A. B. (2004). The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA, 292(18), 2237–2242. doi:https://doi.org/10.1001/jama.292.18.2237
- Zhang, D. A., Lam, V., Chu, V., & Li, M. (2018). Type 2 diabetes with comorbid depression in relation to cognitive impairment: An opportunity for prevention? Molecular Neurobiology, 55(1), 85–89. doi:https://doi.org/10.1007/s12035-017-0719-8